(Q37838299)

24 August 2017

1 reference

title

Recent developments in ruthenium anticancer drugs (English)

1 reference

24 August 2017

1 reference

3

Peter A Lay

0 references

author name string

Aviva Levina

series ordinal

1

1 reference

PubMed ID

21305154

24 August 2017

Anannya Mitra

series ordinal

2

1 reference

24 August 2017

13 August 2009

1 reference

24 August 2017

1 reference

24 August 2017

1

1 reference

24 August 2017

458-470

1 reference

24 August 2017

6

1 reference

INHIBITION OF LANDSCHUETZ ASCITES TUMOUR GROWTH BY METAL CHELATES DERIVED FROM 3,4,7,8-TETRAMETHYL-1,10-PHENANTHROLINE.

24 August 2017

1 reference

How do real tumors become resistant to cisplatin?

21 January 2018

1 reference

(106)Ruthenium brachytherapy for retinoblastoma.

21 January 2018

1 reference

Biomedical applications of X-ray absorption and vibrational spectroscopic microscopies in obtaining structural information from complex systems

21 January 2018

1 reference

Ruthenium Anticancer Compounds: Challenges and Expectations

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.2533/CHIMIA.2007.692

Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development

8 July 2023

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.2533/CHIMIA.2007.698

8 July 2023

Identifiers

DOI

10.1039/B904071D

1 reference

24 August 2017

1 reference

PubMed ID

21305154